A drug that was being developed in Scotland to treat a neglected disease could be repurposed to treat leukaemia after it was given fast track designation by US authorities.
Researchers at the University of Dundee said they are “delighted” after the drug was given the designation by the US Food and Drug Administration (FDA).
